347 related articles for article (PubMed ID: 19482519)
1. Complications associated with single-level transforaminal lumbar interbody fusion.
Rihn JA; Patel R; Makda J; Hong J; Anderson DG; Vaccaro AR; Hilibrand AS; Albert TJ
Spine J; 2009 Aug; 9(8):623-9. PubMed ID: 19482519
[TBL] [Abstract][Full Text] [Related]
2. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers.
Glassman SD; Dimar JR; Burkus K; Hardacker JW; Pryor PW; Boden SD; Carreon LY
Spine (Phila Pa 1976); 2007 Jul; 32(15):1693-8. PubMed ID: 17621221
[TBL] [Abstract][Full Text] [Related]
5. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
Slosar PJ; Josey R; Reynolds J
Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
7. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.
Maeda T; Buchowski JM; Kim YJ; Mishiro T; Bridwell KH
Spine (Phila Pa 1976); 2009 Sep; 34(20):2205-12. PubMed ID: 19752707
[TBL] [Abstract][Full Text] [Related]
8. Posterolateral lumbar spine fusion with INFUSE bone graft.
Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
[TBL] [Abstract][Full Text] [Related]
9. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
[TBL] [Abstract][Full Text] [Related]
10. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
Hiremath GK; Steinmetz MP; Krishnaney AA
Spine (Phila Pa 1976); 2009 Apr; 34(9):885-9. PubMed ID: 19531997
[TBL] [Abstract][Full Text] [Related]
11. The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis.
Rihn JA; Makda J; Hong J; Patel R; Hilibrand AS; Anderson DG; Vaccaro AR; Albert TJ
Eur Spine J; 2009 Nov; 18(11):1629-36. PubMed ID: 19475434
[TBL] [Abstract][Full Text] [Related]
12. Accelerating autograft maturation in instrumented posterolateral lumbar spinal fusions without donor site morbidity.
Rogozinski A; Rogozinski C; Cloud G
Orthopedics; 2009 Nov; 32(11):809. PubMed ID: 19902899
[TBL] [Abstract][Full Text] [Related]
13. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
15. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
[TBL] [Abstract][Full Text] [Related]
16. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion.
Buttermann GR
Spine J; 2008; 8(3):426-35. PubMed ID: 17977799
[TBL] [Abstract][Full Text] [Related]
17. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
[TBL] [Abstract][Full Text] [Related]
18. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
[TBL] [Abstract][Full Text] [Related]
19. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
20. Gluteal-sparing approach for posterior iliac crest bone graft: description of a new technique and assessment of morbidity in ninety-two patients after spinal fusion.
Merritt AL; Spinnicke A; Pettigrew K; Alamin TF
Spine (Phila Pa 1976); 2010 Jun; 35(14):1396-400. PubMed ID: 20551786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
